Actively Recruiting
Articaine Plus Dexmedetomidine in Supraclavicular Block
Led by Benha University · Updated on 2024-05-23
66
Participants Needed
1
Research Sites
28 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Articaine has emerged as a local anesthetic (LA) that produces sensory and motor blockade shorter than bupivacaine and lower in neurotoxicity than lidocaine. Studies have shown that adding dexmedetomidine to LA produces prolongation of sensory and motor bock duration. Early regain of motor power with adequate analgesia is needed in ambulatory surgery, for early start of physiotherapy. This study was designed to test efficacy of adding dexmedetomidine to articaine on the duration of sensory and motor block.
CONDITIONS
Official Title
Articaine Plus Dexmedetomidine in Supraclavicular Block
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Aged 18 to 60 years
- Planned for upper limb surgery below the midhumerus
- Expected surgery duration less than 90 minutes
- Surgery usually performed under tourniquet
You will not qualify if you...
- Allergy to local anesthetics
- American Society of Anesthesiologists (ASA) physical status III or IV
- Refusal to participate
- Uncooperative behavior
- Infection at the site of injection
- Bleeding disorders or use of anticoagulant drugs
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Samar Rafik Mohamed Amin
Banhā, Qalyubia Governorate, Egypt, 13511
Actively Recruiting
Research Team
S
Samar R Amin, MD
CONTACT
E
Elsayed M abdelzaam, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here